𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Open label non comparative study of the efficacy tolerability and safety with fluvastatin (LESCOL®) 40 MG once daily during 12 weeks in 79 Ecuadorian dyslipidemic patients with coronary heart disease

✍ Scribed by J. Páez; L. Alvarado; D. Toral; B. Delgado


Book ID
119439480
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
247 KB
Volume
144
Category
Article
ISSN
0021-9150

No coin nor oath required. For personal study only.